Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.

Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth.

Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...

The "Enterprise Tech Ecosystem Series: Haleon - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into the Haleon's tech activities, including its ...

Haleon launched a share buyback programme of up to £330m on Friday, representing the remaining portion of the £500m allocated ...

(Reuters) -Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional ...

Haleon PLC HLN shares slid 1.91% to £3.86 Monday, on what proved to be an all-around poor trading session for the stock ...

Commonwealth Equity Services LLC lessened its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 3.3% in the fourth ...

Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...